Targeting menopausal hot flushes with non-hormonal treatment

Description

In this Product Explainer, Gynaecologist Prof Rod Baber AM presents the clinical data for fezolinetant, including its impact on hot flush frequency and severity, tolerability profile, and considerations for use in clinical practice (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Michelle Rodrigues

A/Prof Michelle Rodrigues

Acne Scarring

Dr Mitchell Creinin MD

Dr Mitchell Creinin MD

Natural Estrogen, Contraception and Clot Risk

Prof Eugenia Pedagogos

Prof Eugenia Pedagogos

Kidney Function Tests Explained

Dr David Lim & Prof Richard Harvey

Dr David Lim & Prof Richard Harvey

Fireside Discussion – Chronic Sinusitis & Nasal Polyps Management Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Rodney Baber AM

expert

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, Obstetrics and Gynaecology, The University of Sydney; Past President, International Menopause Society and Australasian Menopause Society

Date published: 20 October 2026